Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Sci Adv. 2022 Nov 4;8(44):eadd4920. doi: 10.1126/sciadv.add4920. Epub 2022 Nov 2.
Type II topoisomerases (TOP2) are conserved regulators of chromatin topology that catalyze reversible DNA double-strand breaks (DSBs) and are essential for maintaining genomic integrity in diverse dynamic processes such as transcription, replication, and cell division. While controlled TOP2-mediated DSBs are an elegant solution to topological constraints of DNA, DSBs also contribute to the emergence of chromosomal translocations and mutations that drive cancer. The central importance of TOP2 enzymes as frontline chemotherapeutic targets is well known; however, their precise biological functions and impact in cancer development are still poorly understood. In this review, we provide an updated overview of TOP2A and TOP2B in the regulation of chromatin topology and transcription, and discuss the recent discoveries linking TOP2 activities with cancer pathogenesis.
II 型拓扑异构酶(TOP2)是染色质拓扑的保守调节剂,可催化可逆的 DNA 双链断裂(DSB),对于转录、复制和细胞分裂等多种动态过程中的基因组完整性的维持至关重要。虽然受控的 TOP2 介导的 DSB 是解决 DNA 拓扑约束的一种巧妙方法,但 DSB 也导致了染色体易位和突变的出现,从而推动了癌症的发生。TOP2 酶作为一线化疗靶点的核心重要性是众所周知的;然而,它们在癌症发展中的精确生物学功能和影响仍知之甚少。在这篇综述中,我们提供了关于 TOP2A 和 TOP2B 在染色质拓扑和转录调控中的最新概述,并讨论了将 TOP2 活性与癌症发病机制联系起来的最新发现。